Structures by: Asegbeloyin J. N.
Total: 5
2-[(2,4,6-Trimethylbenzene)sulfonyl]phthalazin-1(2<i>H</i>)-one
C17H16N2O3S
Acta Crystallographica Section E (2020) 76, 5 697-702
a=7.9782(4)Å b=8.1711(5)Å c=12.6661(7)Å
α=92.214(2)° β=93.4230(10)° γ=114.2740(10)°
1,4-Bis(4-methoxyphenyl)-3<i>a</i>-methyltetrahydroimidazo[4,5-<i>d</i>]imidazole-2,5(1<i>H</i>,3<i>H</i>)-dithione
C19H20N4O2S2
Acta Crystallographica Section E (2019) 75, 9 1297-1300
a=13.1955(3)Å b=10.0157(2)Å c=14.5476(3)Å
α=90° β=98.329(2)° γ=90°
<i>N</i>'-[(1<i>E</i>)-1-(6-Methyl-2,4-dioxo-3,4-dihydro-2<i>H</i>-pyran-3-ylidene)ethyl]benzenesulfonohydrazide
C14H14N2O5S
Acta Crystallographica Section E (2014) 70, 11 o1179-o1180
a=7.4797(4)Å b=15.2458(7)Å c=12.7820(6)Å
α=90° β=94.282(3)° γ=90°
<i>N</i>'-[(4<i>Z</i>)-1-(3-Methyl-5-oxo-1-phenyl-4,5-dihydro-1<i>H</i>-pyrazol-4-ylidene)hexyl]benzenesulfonohydrazide
C22H26N4O3S
Acta Crystallographica Section E (2014) 70, 6 o730-o731
a=10.8672(8)Å b=14.0435(10)Å c=14.3584(10)Å
α=90° β=104.302(4)° γ=90°
<i>N</i>-(2-Chloroethyl)morpholine-4-carboxamide
C7H13ClN2O2
Acta Crystallographica Section E (2014) 70, 4 o463
a=10.7393(8)Å b=33.613(3)Å c=9.9942(7)Å
α=90° β=95.704(5)° γ=90°